METASTATIC CERVICAL CARCINOMA
Clinical trials for METASTATIC CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized immune cells tested to fight five tough cancers
Disease control TerminatedThis early-stage study aimed to test the safety and early effectiveness of a personalized cell therapy called STIL101. The therapy involved growing a patient's own cancer-fighting immune cells (T-cells) from a tumor sample in a lab and then infusing them back. It was designed for…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug duo tested in fight against advanced cervical cancer
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, dostarlimab and cobolimab, can help control advanced cervical cancer that has spread or come back. It will involve about 66 adults whose cancer has progressed after standard platinum-based chemotherapy. The m…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Blood test could predict cervical Cancer's return
Knowledge-focused OngoingThis study is testing a new blood test to see if it can find tiny pieces of HPV DNA from cervical cancer in the bloodstream. Researchers want to see if this test can help predict how well treatment is working and detect if the cancer comes back earlier than current methods. The s…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Can blood tests tame Chemo's painful side effects?
Knowledge-focused TerminatedThis study aims to see if doctors can reliably measure the amount of a common chemotherapy drug (paclitaxel) in a patient's blood. The goal is to learn if tracking these levels can help find the right dose to fight cancer while reducing a severe side effect: nerve damage that cau…
Matched conditions: METASTATIC CERVICAL CARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC